Professor Helene McNulty
Research by Professor Helene McNulty and colleagues found that over 26 weeks, daily doses of 0.2, 0.4, or 0.8 mg of folic acid reduced homocysteine concentrations by 14.3%, 14.2%, and 18.3%, respectively, with no significant between-group differences.
The equivalent efficacy of the lower dose is at odds with most previous studies exploring the issue, they reported in the just-published January 2011 issue of the American Journal of Clinical Nutrition.
“Previous trials may have overestimated the folic acid dose required because of too short an intervention period to observe a more complete response to lower doses,” the researchers said.
Fortification of food with folic acid – introduced in the U.S. in the late 1990s – is aimed at reducing neural tube defects. But folic acid also reduces homocysteine levels.
Identifying the lowest effective dose of folic acid is important, according to the researchers, is important because of concerns that high doses may increase the risk of cognitive impairment in older people with low vitamin B12 levels, mask the anemia of vitamin B12 deficiency, and enhance colorectal tumorigenesis in people with preexisting lesions.
The trial was conducted in Northern Ireland, which does not have a mandatory folic acid fortification policy.
After controlling for baseline homocysteine concentration — which was higher in the patients who had ischaemic heart disease — the response to folic acid was similar across the study participants, who were combined for the analyses.
All three doses of folic acid reduced homocysteine levels, regardless of baseline concentration.
“The results are timely,” the researchers said, “because population-wide fortification with folic acid on a mandatory basis (introduced over 10 years ago in North America) is under consideration by various governments worldwide.”
The study was supported by the Northern Ireland Chest Heart and Stroke Association.
Report source: www.medpagetoday.com
For further information, please contact: